Making a Splash in Cystic Fibrosis Research!

News

  • Kudos launches solution to illegal sharing of copyright content
    by News from STM on November 15, 2017 at 9:00 am

    http://blog.growkudos.com/2017/11/15/kudos-solution-illegal-sharing-copyright-content Kudos, the award-winning service for maximizing the reach and impact of research publications, has announced the launch of its shareable PDF solution, which helps publishers prevent copyright infringement and reclaim lost usage from sharing of research articles on scholarly collaboration networks (SCNs). Authors of articles published by the American Thoracic Society, Emerald Publishing, FASEB and The IET can now use Kudos to create summary PDFs of their articles, for uploading to sites like ResearchGate and Academia.edu. The summary PDFs contain links to the full text on the publisher sites, enabling authors to create a record for their work in multiple places, while consolidating and measuring the usage...MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free. […]

  • UAB research shows promise for treating cystic fibrosis
    by bizjournals.com Health Care:Biotechnology headlines on November 8, 2017 at 5:46 pm

    UAB research on a new two-drug combination for treating cystic fibrosis is gaining traction. The new drug therapy has been shown to improve lung function in patients with certain mutations of the CFTR gene, which is responsible for the disease.  UAB's findings, published in the New England Journal of Medicine, show the combinations of the drugs Tezacaftor and Ivacaftor improved lung fun ction by nearly 7 percent compared to a placebo in a subset of patients. The UAB study looked at over 200 cystic… (Source: bizjournals.com Health Care:Biotechnology headlines) […]

  • Battle to get £100,000-a-year cystic fibrosis wonder drug
    by the Mail online | Health on November 4, 2017 at 9:00 pm

    Campaigners hit out last week at health chiefs who have denied NHS England patients access to the £100,000-a-year medication because it is ‘not cost-effective’. (Source: the Mail online | Health) […]

  • NICE's first guideline on cystic fibrosis endorses telemedicine
    by PharmacoEconomics and Outcomes News on October 31, 2017 at 11:00 pm

    (Source: PharmacoEconomics and Outcomes News) […]

  • People with cystic fibrosis could be monitored through phone or video messaging says NICE
    by NHS Networks on October 25, 2017 at 11:00 pm

    Patients with cystic fibrosis could avoid having to travel to specialist clinics if health professionals could monitor them using phone or video messaging. (Source: NHS Networks) […]